Intec Pharma Ltd (NASDAQ:NTEC) CEO Jeffery Meckler talked with Proactive’s Steve Darling at the 12th annual LD Micro Conference. The Jerusalem, Israel-based clinical-stage biopharmaceutical company develops drugs based on its proprietary Accordion Pill platform technology. The innovative Accordion Pill oral drug delivery system boosts the potency of drugs by utilizing efficient gastric retention and specific release mechanism.
Intec Pharma accordion pill technology looking to change the game in drug delivery
Quick facts: Intec Pharma
Price: 0.515 USD
Market Cap: $18.36 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE